---
schema_version: "secwatch.filing_event.v1"
accession: "0000318154-24-000018"
form_type: "8-K"
ticker: "AMGN"
cik: "0000318154"
company_name: "AMGEN INC"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T01:01:30.264532+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Amgen Q1 2024 revenue up 22% to $7.4B; GAAP EPS loss of $0.21 on BeiGene mark-to-market loss

## Summary
- Total revenue $7.4B (+22% YoY); product sales grew 22% driven by 25% volume growth; Horizon contributed $914M.
- GAAP EPS loss of $0.21 vs $5.28 gain YoY, driven by mark-to-market loss on BeiGene equity investment.
- Non-GAAP EPS $3.96 (-1% YoY); non-GAAP operating income $3.1B (+11% from $2.8B).
- Ten products delivered double-digit volume growth including Repatha, TEZSPIRE, EVENITY, BLINCYTO, TAVNEOS.
- Free cash flow $0.5B vs $0.7B; decrease from $800M tax deposit partially offset by working capital timing.

## SEC filing metadata
- accession: 0000318154-24-000018
- form_type: 8-K
- ticker: AMGN
- cik: 0000318154
- company_name: AMGEN INC
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318154/000031815424000018/0000318154-24-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318154/000031815424000018/amgn-20240502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000318154-24-000018
- JSON: https://secwatch.observer/filing/0000318154-24-000018.json
- Plain text: https://secwatch.observer/filing/0000318154-24-000018.txt

## Key facts
- Earnings Releases
  AMGEN INC reported first quarter 2024 results: revenue $7.4 billion, EPS $3.96.
  - Period: first quarter 2024
  - Revenue: $7.4 billion
  - EPS: $3.96
  - Result: reported results
  source text: For the first quarter, total revenues increased 22% to $7.4 billion in comparison to the first quarter of 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/318154/000031815424000018/0000318154-24-000018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.